The 2023 Belgian clinical guidance on anticoagulation management in hospitalized and ambulatory COVID-19 patients ...

COVID-19 is associated with an increased risk for thrombotic complications. The trials investigating the optimal thromboprophylactic dose are performed in challenging times and seemingly produce conflicting evidence. The burdensome circumstances, divergent endpoints, and different analytical approaches hamper comparison and extrapolation of available evidence. Most importantly, clinicians should provide thromboprophylaxis in hospitalized COVID-19 patients while (re)assessing bleeding and thrombotic risk frequently. The COVID-19 Thromboprophylaxis Working Group of the BSTH updated its guidance... Mehr ...

Volltext
Verfasser: Vanassche, Thomas
Engelen, Matthias M
Orlando, Christelle
Vandenbosch, Kristel
Gadisseur, Alain
Hermans, Cedric
Jochmans, Kristin
Minon, Jean-Marc
Motte, Serge
Peperstraete, Harlinde
Péters, Pierre
Sprynger, Muriel
Lancellotti, Patrizio
Dehaene, Isabelle
Emonts, Patrick
Vandenbriele, Christophe
Verhamme, Peter
Oury, Cecile
Dokumenttyp: Journal contribution
Erscheinungsdatum: 2023
Verlag/Hrsg.: Taylor & Francis
Schlagwörter: Medicine / Sociology / FOS: Sociology / Information Systems not elsewhere classified / Cancer / Hematology / Infectious Diseases / FOS: Health sciences
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-28885016
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.23899472

COVID-19 is associated with an increased risk for thrombotic complications. The trials investigating the optimal thromboprophylactic dose are performed in challenging times and seemingly produce conflicting evidence. The burdensome circumstances, divergent endpoints, and different analytical approaches hamper comparison and extrapolation of available evidence. Most importantly, clinicians should provide thromboprophylaxis in hospitalized COVID-19 patients while (re)assessing bleeding and thrombotic risk frequently. The COVID-19 Thromboprophylaxis Working Group of the BSTH updated its guidance document. It aims to summarize the available evidence critically and to guide clinicians in providing the best possible thromboprophylaxis. ...